source
- Beeline Medicines secures $126M from Bain Capital, CPPIB and Bristol Myers to expand immunology pipelineBeeline Medicines, a spinout from Bristol Myers Squibb, announced it has received an additional $126 million in financing. The new capital comes from existing investors Bain Capital and the Canada…
- FDA reviewers recommend against adding seven peptides to bulk drug list for compoundingFDA reviewers have advised that seven widely used peptides should not be added to the FDA's bulk drug substance list for compounding. Their recommendation comes before an upcoming advisory committe…